@article{oai:repo.qst.go.jp:00077716,
 author = {Matsuda, Hiroshi and Yokoyama, Kota and Sato, Noriko and Ito, Kengo and Nemoto, Kiyotaka and Oba, Hiroshi and Hanyu, Haruo and Kanetaka, Hidekazu and Mizumura, Sunao and Kitamura, Shin and Shinotoh, Hitoshi and Shimada, Hitoshi and Suhara, Tetsuya and Terada, Hitoshi and Nakatsuka, Tomoya and Kawakatsu, Shinobu and Hayashi, Hiroshi and Asada, Takashi and Ono, Tetsutaro and Goto, Tomoaki and Shigemori, Keiko and Hiroshi, Matsuda and Sato, Noriko and Hitoshi, Shinoto and Hitoshi, Shimada and Tetsuya, Suhara},
 journal = {Neuropsychiatric Disease and Treatment},
 month = {Sep},
 note = {Dementia with Lewy bodies (DLB) is one of the main etiologies of neurodegenerative dementia after Alzheimer’s disease (AD).1 Distinguishing DLB from AD is difficult because of their overlapping clinical and pathological features.2–4 Patients with clinically defined DLB may also have AD-type pathological changes as well as the characteristic Lewy bodies. However, the differential diagnosis is particularly important because DLB respond better to cholinesterase inhibitors but are sensitive to neuroleptics, which cause worsening of clinical status.},
 pages = {2715--2722},
 title = {Differentiation Between Dementia With Lewy Bodies  And Alzheimer’s Disease Using Voxel-Based  Morphometry Of Structural MRI:AMulticenter Study},
 volume = {15},
 year = {2019}
}